Related Experiment Video

Updated: Aug 9, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Accrual delayed in adjuvant bevacizumab trial

Rabiya S Tuma

    Journal of the National Cancer Institute
    |April 6, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 9, 2026

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Related Concept Videos

    Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

    Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

    Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
    Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

    Drug Accumulation During Multiple Dosing: Repetitive IV Injections

    Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...

    Articles linked to this work by shared authors, journal, and citation graph.

    Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

    Journal of the National Cancer Institute·2026

    Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.

    Journal of the National Cancer Institute·2026

    Examining the role of extrachromosomal DNA in lung cancer.

    Journal of the National Cancer Institute·2026

    Differential impact of lymphocytes on radiation response in autochthonous vs transplant murine sarcomas.

    Journal of the National Cancer Institute·2026

    Nitrate and nitrite intake and risk of colorectal cancer: a population-based cohort study.

    Journal of the National Cancer Institute·2026

    The joint association of clonal hematopoiesis of indeterminate potential and biological aging with cancer risk among 332,911 individuals.

    Journal of the National Cancer Institute·2026

    Immunometabolic Effects of SGLT2 Inhibitors on the Th17/Treg Axis: Mechanisms, Evidence, and Implications for Therapeutic Repurposing.

    Molecular biology reports·2026

    Predicting intestinal ischemia in mechanical intestinal obstruction: the role of the C-reactive protein-albumin-lymphocyte index.

    Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES·2026

    Low versus high inferior mesenteric artery ligation and gastrointestinal quality of life following anterior resection for rectal cancer.

    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina·2026

    Using cell-free RNA to identify B- and T-cell clonality for diagnosis and monitoring of B- and T-cell neoplasms.

    FEBS open bio·2026

    ICG-guided bowel preservation during emergency TAPP repair for incarcerated Spigelian hernia: a case report.

    Journal of surgical case reports·2026

    Severe radiodermatitis and implant loss associated with pembrolizumab and olaparib following pre-pectoral breast reconstruction in a 31-year-old female: a case report.

    AME case reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us